Science Corporation implants its vision-restoring chip in its first Stargardt disease patient
Max Hodak, the former president and co-founder of Neuralink, detailed onstage at TechCrunch Disrupt how his company's work with PRIMA is part of its path toward a novel brain-computer interface (BCI).
Se muestra el contenido original; la traduccion localizada aun no esta disponible.
Qué ocurrió
Max Hodak, the former president and co-founder of Neuralink, detailed onstage at TechCrunch Disrupt how his company's work with PRIMA is part of its path toward a novel brain-computer interface (BCI).
Por que importa
The development may change operating conditions or market expectations around AI. Further confirmation and measurable outcomes matter.
Entidades afectadas
Ver evidencia
1 articulos · 1 informe original · 1 independientes
- TechCrunch AIFuente primaria · Respalda · EN · 100%Science Corporation implants its vision-restoring chip in its first Stargardt disease patient ↗
Afirmaciones
- Science Corporation implants its vision-restoring chip in its first Stargardt disease patient Observado
Conflictos
No se detectaron conflictos importantes en la evidencia disponible.
Cronología
- Primera publicación
Movimiento del mercado posterior al evento
La reacción del mercado aún no está disponible para este activo y periodo.